Algeta schedules fourth quarter and full year 2012 results presentation, webcast and conference call OSLO, NORWAY -- (Marketwire) -- 02/18/13 -- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, will announce its fourth quarter and full year 2012 results on Thursday, 28 February 2013. A presentation by Algeta's senior management team to investors, analysts and the press will take place in Oslo at 10:00 CET. The presentation will also be webcast live and can be accessed through www.algeta.com where questions can also be submitted during the presentation. The presentation will take place at 10:00 CET at: Shippingklubben Haakon VIIs gate 1 0161 Oslo Norway. Algeta's senior management will also host an international conference call at 14:30 CET/08:30 Eastern Time (US) (details below). To participate in the conference call, please dial the appropriate number below five minutes prior to the call: US: +1 877 423 0830 UK: +44 20 7153 9154 Norway: +47 21 06 61 13 Sweden: +46 8-506 443 86 Denmark: +45 32 71 42 62 Switzerland: +41 44 580 65 22 Participant pin code: 434633# To access the replay, please dial: US: +1 877 679 2989 UK: +44 20 3364 5196 Norway: +47 23 50 02 03 Sweden: +46 8-505 564 73 Conference reference: 345360# A replay version of the conference call will also be available at www.algeta.com. The results report and the presentation will be available at www.algeta.com in the Investors section from 07:00 CET. About Algeta Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com. Press release: http://hugin.info/134655/R/1678620/547936.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they ar e solely responsible for the content, accuracy and originality of the information contained therein. Source: Algeta ASA via Thomson Reuters ONE [HUG#1678620] For further information, please contact: Mike Booth / Renate Birkeli +47 23 00 67 32 Communications & Corporate Affairs email@example.com Media enquiries: Mark Swallow +44 207 638 9571 Citigate Dewe Rogerson firstname.lastname@example.org Knut Ekern +47 22 04 82 00 Gambit Hill & Knowlton email@example.com Kari Watson +1 781 235 3060 MacDougall Biomedical Communications firstname.lastname@example.org US investor enquiries: Tricia Swanson +1 646 378 2953 The Trout Group email@example.com
Algeta schedules fourth quarter and full year 2012 results presentation, webcast and conference call
Press spacebar to pause and continue. Press esc to stop.